A research team of 22 researchers from 11 countries investigating means to defeat pertussis, or whooping cough, has received €28 million funding for creating a novel vaccine. Participants from Finland include a team of researchers from the University of Turku, who explore the resistance created by the vaccine and the immunity caused by pertussis.
Children cannot be given the vaccine until the age of 2–3 months. For people without vaccination, pertussis can be lethal.
The research groups of the unit study the role of microbes and immune system in health and diseases, and the laboratory diagnostics and treatment of infectious and other inflammatory diseases.
UTU Research – Faculty of Medicine or shortly RFM, gathers the principal investigators at the Faculty of Medicine.